He is teasing this new young biotech company but I believe he is wrong. Merck put out the Keytruda drug, approved by FDA for Melanoma and also lung cancer. I’m pretty sure Carter used Keytruda. These immunotherapeutic drugs (Like Keytruda by Merck and Optidiva by BMY) have proven remarkable, but do not sound like this the small drug company cited.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
The teaser spoken of above talks about Engineered T-Cell therapy or I-Cell Therapy as Chris Schaeffer with Agora Financial calls it. I’m wondering if they might be talking about Juno Therapeutics … Please advise …
Thanks,
Bob Pashos
Regardless of the drug or company If I were a betting man I believe carter will not last more than another 6-12 months at most